BackEntasis Therapeutics Holdings Overview

Entasis Therapeutics Holdings Operating Income

Operating Income for ETTX.

Quarterly Operating Income

$-15252000.00
20.31% YoY

As of Mar 31, 2022

Annual Operating Income (TTM)

$-89292000.00
73.37% YoY

Trailing 12 months ending Mar 31, 2022

Average Operating Income (Comparison Companies)

Operating Income History

Operating Income Comparison

Annual Operating Income Growth Rate (%)

Annual Operating Income Growth (Absolute)